Skip to main content
VulnerabilityPublished

CVE-2025-62575: NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database

Source GCVE Database

0
Compare
Authoritative record:CVE-2025-62575· High 8.7

Not known to be exploited · CVSS 8.7 High.

Data as of 22 Nov 2026, 02:48 UTC

CVSS 4.0 base score
8.7High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (icscert)CVSS 4.08.7
CNA (icscert)CVSS 3.18.3
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Dec 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 21 Nov 2026.

What to do

AI-suggested

Users should immediately review and restrict the privileges of the 'nmdbuser' and any other default accounts to the minimum necessary, removing sysadmin rights. Monitor vendor advisories for any forthcoming official fixes or updates.

Description

NMIS/BioDose versions 22.02 and earlier use a Microsoft SQL Server database where the default SQL user account 'nmdbuser' and other created accounts have sysadmin privileges. This misconfiguration allows remote code execution via certain built-in stored procedures.

References

Community reviews

Loading reviews…